Related Experiment Video
Updated: Jan 25, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
The influence of sex on left ventricular remodeling in arterial hypertension
Marijana Tadic1, Cesare Cuspidi2, Guido Grassi3
1Department of Internal Medicine and Cardiology, Charité-Universitätsmedizin Berlin, Augustenburgerplatz 1, 13353, Berlin, Germany. marijana_tadic@hotmail.com.
Insights
Hypertension impacts heart failure risk differently in men and women. Sex hormones influence cardiac remodeling, leading to varied left ventricular changes and heart failure prevalence between sexes.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Hypertension Research
Background:
- Arterial hypertension is a primary cardiovascular risk factor for heart failure (HF).
- Sex hormones significantly influence hypertension prevalence and target organ damage, particularly in women.
- Left ventricular (LV) remodeling occurs in both sexes due to hypertension but differs in prevalence and manifestation.
Purpose of the Study:
- To review sex-related differences in LV remodeling in patients with arterial hypertension.
- To explore the underlying mechanisms, particularly the role of sex hormones, in these sex-specific changes.
- To provide an updated overview of current data on hypertension-induced LV alterations.
Main Methods:
- Literature review of studies investigating sex differences in hypertension and heart failure.
- Analysis of data on left ventricular structural, functional, and mechanical changes.
- Examination of the role of sex hormones and biohumoral systems in cardiac remodeling.
Main Results:
- Left ventricular hypertrophy prevalence is higher in men.
- Data on LV diastolic dysfunction and mechanical changes show inconsistencies between sexes.
- LV longitudinal strain is lower in hypertensive men, though this trend exists in healthy populations too.
Conclusions:
- Sex hormones are key mechanisms driving sex-related LV remodeling in hypertension.
- Significant sex-specific variations exist in LV remodeling and HF development.
- Further research is needed to clarify sex-specific cutoffs for LV mechanical dysfunction.
Abstract:
Hypertension represents one of the most important and most frequent cardiovascular risk factors responsible for heart failure (HF) development. Both sexes are equally affected by arterial hypertension. The difference is lying in the fact that prevalence of hypertension as well as hypertension-induced target organ damage varies during lifetime due to substantial variation of sex hormones in women. Left ventricular (LV) structural, functional, and mechanical changes induced by hypertension are well-known complications that occur in both sexes and they are responsible for HF development. However, their prevalence is significantly different between women and men, which could potentially explain the variation in HF occurrence and prognosis between the sexes. Studies have shown that the prevalence of left ventricular hypertrophy is higher in men. The data are not consistent regarding LV diastolic dysfunction and a similar report has been given for LV mechanical changes. Most investigations agree that LV longitudinal strain is lower among hypertensive men. However, even in the healthy population, men have lower LV longitudinal strain and the cutoff values are still missing. Therefore, it would be difficult to draw the conclusion that LV mechanical dysfunction is more prevalent among men. The main mechanisms responsible for sex-related LV remodeling are sex hormones and their influence on biohumoral systems. This review provides an updated overview of the available data about sex-related LV remodeling, as well as potential mechanisms for these changes, in the patients with arterial hypertension.
More Related Videos
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
07:41A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
Related Concept Videos
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Sex-linked Disorders